Search

everythinglearnresearchcommunity

for

Search:↓

Older patients without prior JAK inhibitor treatment respond best to tofacitinib for alopecia areata.

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

Oclacitinib effectively treated a skin condition in dogs that didn't respond to other immunosuppressants.

Machine learning can predict how well patients with alopecia areata will respond to certain treatments.

Healthcare claims databases can help monitor drug safety, but may report adverse events differently than direct surveillance.

Baricitinib is effective in promoting hair growth in severe alopecia areata.

Suppressing eIF4E can prevent hair loss from chemotherapy.

Hinokiflavone may help treat cancers and other health issues.

Baricitinib was effective in regrowing eyebrow and eyelash hair in patients with severe alopecia areata.

Baricitinib successfully treated severe hair loss.

Erlotinib can cause hair loss and texture changes.

Abrocitinib significantly improved hair regrowth in adolescents with alopecia areata without serious safety issues.

TGF-β inhibitors may help treat liver fibrosis by targeting various pathways.

Blocking mTORC1 activity with rapamycin could help increase hair pigmentation and growth, potentially reversing gray hair.

Certain herbal compounds, especially from bitter melon, can inhibit cancer growth and promote hair growth by blocking PAK1.

Pembrolizumab can cause serious liver issues, requiring close monitoring and early treatment.

Ruxolitinib cream effectively targets and treats inflammatory skin diseases.

Sintilimab treatment caused hair loss but led to complete tumor remission.

Ocoxin improves quality of life for advanced ovarian cancer patients on chemotherapy.

A woman's hair turned gray and fell out after starting a cancer drug called imatinib mesylate.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

ATP helps prevent skin damage from vandetanib by reducing stress.

Using CDK inhibitors on rats showed a reduction in chemotherapy-caused hair loss, but later experiments could not repeat these results.

Ritlecitinib effectively maintains hair regrowth in alopecia areata patients.

A 14-year-old girl with severe hair loss regrew her hair using upadacitinib.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

Medicaid coverage for alopecia areata treatments is inconsistent and often limited.

Baricitinib effectively promotes hair regrowth in severe alopecia with minimal side effects.